| Bioactivity | Zifcasiran sodium is a hypoxia-inducible factor (HIF) synthesis reducer. Zifcasiran sodium shows antitumor activities and can be used in advanced renal cell carcinoma research[1][2]. |
| Name | Zifcasiran sodium |
| CAS | 2437257-12-8 |
| Formula | C737H929F20N211Na52O349P43S8 |
| Molar Mass | 21491.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true [2]. https://searchusan.ama-assn.org/usan/documentDownload?uri=%2Funstructured%2Fbinary%2Fusan%2Fzifcasiran-sodium.pdf |
Zifcasiran sodium
CAS: 2437257-12-8 F: C737H929F20N211Na52O349P43S8 W: 21491.26
Zifcasiran sodium is a hypoxia-inducible factor (HIF) synthesis reducer. Zifcasiran sodium shows antitumor activities an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.